StaClear Low-Particulate Ophthalmic Syringe Receives CE Mark Under New EU MDR Requirements
RALEIGH, North Carolina, [July 15, 2025] – StaClear, Inc. today announced that its low-particulate ophthalmic syringes have received CE marking under the updated European Medical Device Regulation (EU MDR), affirming compliance with the latest EU safety, quality, and performance standards.
One Compounding Pharmacy’s Experience With StaClear Syringes
“Our syringe rejection rate went down dramatically with the StaClear syringes. This saves us money, time, and headaches from a Quality perspective."
An interview with Mike Basista, Supervising Pharmacist at RC Outsourcing, LLC a leading 503B outsourcing facility in the United States serving retina specialists
